Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) EPS (Basic) (2016 - 2025)

Integra Lifesciences Holdings' EPS (Basic) history spans 17 years, with the latest figure at -$0.03 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 112.0% year-over-year to -$0.03; the TTM value through Dec 2025 reached -$6.74, down 7388.89%, while the annual FY2025 figure was -$6.74, 7388.89% down from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.03 at Integra Lifesciences Holdings, up from -$0.07 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.65 in Q4 2022 and bottomed at -$6.31 in Q2 2025.
  • The 5-year median for EPS (Basic) is $0.26 (2023), against an average of -$0.09.
  • The largest annual shift saw EPS (Basic) surged 9511.78% in 2021 before it crashed 3843.75% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at $0.54 in 2021, then rose by 20.37% to $0.65 in 2022, then plummeted by 60.0% to $0.26 in 2023, then decreased by 3.85% to $0.25 in 2024, then crashed by 112.0% to -$0.03 in 2025.
  • Per Business Quant, the three most recent readings for IART's EPS (Basic) are -$0.03 (Q4 2025), -$0.07 (Q3 2025), and -$6.31 (Q2 2025).